Delivery Order SPE2DB20D3103-SPE2DB23FL5L8
Award Date 11/7/22
Potential Completion Date 11/8/22
Potential Value $2.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,203.70 to AmerisourceBergen Drug Corp for the supply of Methotrexate 2.5 mg tablets in unit dose packaging (20 count) on January 26, 2026, with completion scheduled for January 27, 2026. This competitively awarded, firm fixed-price delivery order was placed without set-aside restrictions and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc.,...
- The Defense Logistics Agency awarded a $373,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 units of 2.5 mg methotrexate tablets. As one of the largest pharmaceutical distributors supporting the Department of Defense supply chain, Amerisourcebergen will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania by July 20, 2023 to fulfill DLA requirements. The delivery order was issued under an existing DLA-wide supply...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,951.56 Firm Fixed Price Delivery Order covers the supply of 4,565,087,756 units of Methotrexate 2.5 mg Tablets in 100-count bottles, with a completion date of July 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award is for the delivery of Methotrexate 2.5 mg tablets, with a ceiling value of $2,358.37 and a completion date of November 3, 2023. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Methotrexate 2.5 mg tablets. The contract has a ceiling value of $9,777.14 and an ultimate completion date of May 1, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., the parent company of AmerisourceBergen Drug Corp. This IDC, valued at up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of METHOTREXATE 2.5 MG TABLET 100S. The contract has a ceiling value of $8,542.21 and is a Firm Fixed Price Delivery Order with a performance period ending on May 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,500.64, is for the delivery of Methotrexate 2.5 mg tablets (100 count) to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of May 22, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 2.5 mg methotrexate tablets in 100-count packages, with a ceiling value of $1,240.16 and a period of performance through July 2, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
- This federal contract award is a delivery order valued at $6,361.41 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of methotrexate 2.5 mg tablets and has a completion date of November 5, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- The Defense Logistics Agency awarded a delivery order under an indefinite-delivery/indefinite-quantity contract vehicle to Amerisourcebergen Drug Corporation for the supply of 100 units of 2.5 mg methotrexate tablets at a value of $573.57. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period concluding on July 27, 2023. The firm fixed price contract has no set-aside designation and supports the DLA's medical supply procurement programs. As...